Streptococcus pneumoniae

Albanese BA, Roche JC, Pass M, Whitney CG, McEllistrem MC, Harrison LH et al.
Geographic, demographic, and seasonal differences in penicillin-resistant Streptococcus pneumoniae in Baltimore.
Clinical Infectious Diseases 2002; 34(1):15-21.

Beall B, McEllistrem MC, Gertz RE, Jr., Boxrud DJ, Besser JM, Harrison LH et al.
Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States.
Journal of Infectious Diseases 2002; 186(1):118-122.

Farley MM, Baughman W, Arnold KE.
The Georgia Emerging Infections Program: monitoring trends in invasive pneumococcal disease.
Journal of the Medical Association of Georgia 91(2):20-3, 2002.

McEllistrem MC, Mendelsohn AB, Pass MA, Elliott JA, Whitney CG, Kolano JA et al.
Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection.
Journal of Infectious Diseases 2002; 185(9):1364-1368.

McEllistrem MC, Mendelsohn AB, Pass M, Elliott JA, Whitney CG, Albanese BA et al.
Distribution of penicillin-nonsusceptible pneumococcal clones in the Baltimore metropolitan area and variables associated with drug resistance.
Clinical Infectious Diseases 2002; 34(5):704-707.

Morita JY, Zell ER, Danila R, Farley MM, Hadler J, Harrison LH et al.
Association between anti- microbial resistance among pneumococcal isolates and burden of invasive pneumococcal disease in the community.
Clinical Infectious Diseases 2002; 35(4):420-427.

Shevlin JD, Summers-Bean C, Thomas D, Whitney CG, Todd D, Ray SM.
A systematic approach for increasing pneumococcal vaccination rates at an inner-city public hospital.
American Journal of Preventive Medicine 2002; 22(2):92-97.

Centers for Disease Control and Prevention.
Assessment of susceptibility testing practices for Streptococcus pneumoniae—-United States,
February 2000. Morbidity and Mortality Weekly Report 2002; 51(18):392-394.

Group A streptococcus

Chuang I, Van Beneden C, Beall B, Schuchat
A. Population-based surveillance for postpartum invasive group a streptococcus infections, 1995-2000.
Clinical Infectious Diseases 2002; 35(6):665-670.

O'Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM et al.
Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.
Clinical Infectious Diseases 2002; 35(3):268-276.

The Prevention of Invasive Group.
Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention.
Clinical Infectious Diseases 2002; 35(8):950-959.

.Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS et al.
A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. [see comments.].
New England Journal of Medicine 2002; 347(4):233-239.

Schuchat A, Roome A, Zell ER, Linardos H, Zywicki S, O'Brien KL.
Integrated monitoring of a new group B streptococcal disease prevention program and other perinatal infections.
Maternal & Child Health Journal 6(2):107-14, 2002.

Neisseria meningitidis

Kellerman SE, McCombs K, Ray M, Baughman W, Reeves MW, Popovic T et al.
Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease.
Journal of Infectious Diseases 2002; 186(1):40-48.

Haemophilus influenzae

Centers for Disease Control and Prevention.
Progress toward elimination of Haemophilus influenzae type be invasive disease among infants and children—United States, 1998-2000.
Morbidity and Mortality Weekly Report 2002; 51(11):234-237.

Others

Arthington-Skaggs BA, Lee-Yang W, Ciblak MA, Frade JP, Brandt ME, Hajjeh RA et al.
Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates.
Antimicrobial Agents & Chemotherapy 46(8):2477-81, 2002.

Hyde TB, Hilger TM, Reingold A, Farley MM, O'Brien KL, Schuchat A.
Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta.
Pediatrics 2002; 110(4):690-695.

Schrag SJ, Zell ER, Schuchat A, Whitney CG.
Sentinel surveillance: a reliable way to track antibiotic resistance in communities?
Emerging Infectious Diseases 2002; 8(5):496-502.

Additional publications may be found at the following website:

http://www.cdc.gov/ncidod/osr/EIP.htm